BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27510266)

  • 1. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I.
    Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L
    Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
    VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
    Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
    Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
    J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
    Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
    J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
    Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
    Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
    Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
    Hickey RD; Mao SA; Glorioso J; Elgilani F; Amiot B; Chen H; Rinaldo P; Marler R; Jiang H; DeGrado TR; Suksanpaisan L; O'Connor MK; Freeman BL; Ibrahim SH; Peng KW; Harding CO; Ho CS; Grompe M; Ikeda Y; Lillegard JB; Russell SJ; Nyberg SL
    Sci Transl Med; 2016 Jul; 8(349):349ra99. PubMed ID: 27464750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.
    Elgilani F; Mao SA; Glorioso JM; Yin M; Iankov ID; Singh A; Amiot B; Rinaldo P; Marler RJ; Ehman RL; Grompe M; Lillegard JB; Hickey RD; Nyberg SL
    Am J Pathol; 2017 Jan; 187(1):33-41. PubMed ID: 27855279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1.
    Hickey RD; Nicolas CT; Allen K; Mao S; Elgilani F; Glorioso J; Amiot B; VanLith C; Guthman R; Du Z; Chen H; Harding CO; Kaiser RA; Nyberg SL; Lillegard JB
    Cell Transplant; 2019 Jan; 28(1):79-88. PubMed ID: 30477316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
    Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F
    J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity.
    Jacobs SM; van Beurden DH; Klomp LW; Berger R; van den Berg IE
    Pediatr Res; 2006 Mar; 59(3):365-70. PubMed ID: 16492973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
    Aponte JL; Sega GA; Hauser LJ; Dhar MS; Withrow CM; Carpenter DA; Rinchik EM; Culiat CT; Johnson DK
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):641-5. PubMed ID: 11209059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
    Blackburn PR; Hickey RD; Nace RA; Giama NH; Kraft DL; Bordner AJ; Chaiteerakij R; McCormick JB; Radulovic M; Graham RP; Torbenson MS; Tortorelli S; Scott CR; Lindor NM; Milliner DS; Oglesbee D; Al-Qabandi W; Grompe M; Gavrilov DK; El-Youssef M; Clark KJ; Atwal PS; Roberts LR; Klee EW; Ekker SC
    Hum Mutat; 2016 Oct; 37(10):1097-105. PubMed ID: 27397503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation.
    Chen J; Yang T; Song S; Liu Q; Sun Y; Zhao L; Fu Z; Wang MJ; Hu YP; Chen F
    Biochem Biophys Res Commun; 2019 Aug; 516(2):591-598. PubMed ID: 31239154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of lethal hepatic failure by hepatized lymph nodes in mice.
    Hoppo T; Komori J; Manohar R; Stolz DB; Lagasse E
    Gastroenterology; 2011 Feb; 140(2):656-666.e2. PubMed ID: 21070777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
    Morrow G; Angileri F; Tanguay RM
    Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
    Overturf K; Al-Dhalimy M; Manning K; Ou CN; Finegold M; Grompe M
    Hum Gene Ther; 1998 Feb; 9(3):295-304. PubMed ID: 9508047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells.
    Endo F; Sun MS
    J Inherit Metab Dis; 2002 May; 25(3):227-34. PubMed ID: 12137232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.
    Morrow G; Tanguay RM
    Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
    Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
    J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.